Versant Capital Management, Inc Myriad Genetics Inc Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 80 shares of MYGN stock, worth $482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 185
56.76%
Holding current value
$482
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding MYGN
# of Institutions
233Shares Held
94.1MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$29 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$27.7 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...